The Lancet Infectious Diseases, 1473-3099

Journal

1 - 10 out of 22Page size: 10

Publications

  1. 2019
  2. Published

    Cost-effectiveness of outpatient parenteral antibiotic therapy for children with cellulitis

    Raymond Oppong & Shay Kodabuckus, Oct 2019, In : The Lancet Infectious Diseases. 19, 10, p. 1041-1042 2 p.

    Research output: Contribution to journal › Comment/debate

  3. Published

    Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study

    Yemisi Takwoingi, Christopher Partlett, Jon Deeks, 1 Feb 2019, In : The Lancet Infectious Diseases. 19, 2, p. 193-202 10 p.

    Research output: Contribution to journal › Article

  4. 2018
  5. Published

    Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study

    Alice Sitch, Jon Deeks & 7 others, , Oct 2018, In : The Lancet Infectious Diseases. 18, 10, p. 1077-1087

    Research output: Contribution to journal › Article

  6. E-pub ahead of print

    Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

    Aneel Bhangu, 13 Feb 2018, In : The Lancet Infectious Diseases.

    Research output: Contribution to journal › Article

  7. 2017
  8. E-pub ahead of print

    Addressing antimicrobial resistance in the UK and Europe

    Laura Piddock, 10 Nov 2017, In : The Lancet Infectious Diseases.

    Research output: Contribution to journal › Comment/debate

  9. Published

    To the G20: incentivising antibacterial research and development

    Laura Piddock, Aug 2017, In : The Lancet Infectious Diseases. 17, 8, p. 799-801

    Research output: Contribution to journal › Comment/debate

  10. 2016
  11. Published

    Risk of reproductive complications following chlamydia testing

    Malcolm Price, Nov 2016, In : The Lancet Infectious Diseases. 16, 11, p. 1223-1224

    Research output: Contribution to journal › Comment/debate

  12. Published

    Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance.

    Laura Piddock, Jul 2016, In : The Lancet Infectious Diseases. p. 767-768 1 p.

    Research output: Contribution to journal › Letter

  13. E-pub ahead of print

    Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    David Mutimer & 6 others, , 18 Feb 2016, In : The Lancet Infectious Diseases.

    Research output: Contribution to journal › Article

  14. Published

    Alternatives to antibiotics – a pipeline portfolio review

    Ian Henderson & 4 others, Chris Thomas, Feb 2016, In : The Lancet Infectious Diseases. 16, 2, p. 239–251 13 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next